Efficacy and Safety of Rozanolixizumab in Moderate to Severe Generalized Myasthenia Gravis: A Phase 2 Randomized Control Trial

on behalf of the MG0002 Investigators

Research output: Contribution to journal › Article › peer-review

95 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and Safety of Rozanolixizumab in Moderate to Severe Generalized Myasthenia Gravis: A Phase 2 Randomized Control Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences